万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
常温,避光
- 克隆性:
单克隆
- 抗体名:
KIT / c-KIT / CD117抗体
免疫原 :
Recombinant Human KIT / c-KIT / CD117 protein (Catalog#11996-H08H)
Antibody Type : Mouse Monoclonal Antibody ( Mouse mAb Service Platform )
克隆号 :
02
抗体宿主 :
Mouse IgG1
缓冲液 : 0.2 μm filtered solution in PBS, 5% trehalose may be added in some batches. Please read the hardcopy of COA or contact our customer service to confirm the formulation.
制备方法 :
This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human KIT / c-KIT / CD117 (rh KIT / c-KIT / CD117; Catalog#11996-H08H; P10721-2; Met1-Thr516). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.
KIT / c-KIT / CD117抗体Background
Mast / stem cell growth factor receptor, also known as Proto-oncogene c-Kit, Tyrosine-protein kinase Kit, CD117 and KIT, is a single-pass type I membrane protein which belongs to theprotein kinase superfamily, Tyr protein kinase family and CSF-1/PDGF receptor subfamily. CD117 / KIT contains fiveIg-like C2-type (immunoglobulin-like) domains and oneprotein kinase domain. CD117 / KIT is the receptor for stem cell factor (mast cell growth factor). It has a tyrosine-protein kinase activity. Binding of the ligands leads to the autophosphorylation of KIT and its association with substrates such as phosphatidylinositol 3-kinase (Pi3K). CD117 is the receptor for the cytokine stem cell factor (SCF), when this receptor binds to SCF it forms a dimer that activates signaling through second messengers. Signaling through CD117 plays a role in cell survival, proliferation, and differentiation. Defects in CD117 / KIT are a cause of piebaldism which is an autosomal dominant genetic developmental abnormality of pigmentation characterized by congenital patches of white skin and hair that lack melanocytes. Defects in CD117 / KIT have also been associated with testicular tumors (TEST) which is a common solid malignancy in males.
KIT / c-KIT / CD117抗体相关产品如下:
hz-6576R RBBP6视网膜母细胞瘤结合蛋白6抗体
hz-6574R RRBP1核糖体结合蛋白1抗体
hz-6573R RPL5核糖体蛋白L5抗体
hz-6581R RNA polymerase II CTD repeat YSPTSPS (phospho S2)磷酸化RNA聚合酶II CTD抗体
hz-6582R RNA polymerase II CTD repeat YSPTSPS (phospho S5)磷酸化RNA聚合酶II CTD抗体
hz-6583R RNASE4血管生成素核糖核酸酶4抗体(肌萎缩性侧索硬化症蛋白)
hz-6572R RPL19核糖体蛋白L19抗体
hz-5722R RASL10ARas样蛋白家族10A抗体
hz-5706R RASSF4Ras相关区域家族蛋白4抗体
hz-9626R RPUSD2RNA尿苷酸合酶结构域蛋白2抗体
hz-9225R RNF14环指蛋白14抗体
hz-9007R RCBTB1鸟嘌呤核苷酸交换因子抗体
hz-9653R RBFA核糖体结合因子RBFA抗体
hz-9231R RNF166环指蛋白166抗体
hz-11030R RP1视网膜色素变性蛋白1抗体
hz-11257R RAB10G蛋白结合蛋白RAB10抗体
hz-11258R Rab11AG蛋白结合蛋白RAB11a抗体
hz-11259R RAB6AG蛋白结合蛋白RAB6A抗体
hz-11243R Rab17RAS癌基因相关蛋白RAB17抗体
hz-11244R RAB38G蛋白结合蛋白RAB38抗体
hz-11230R RAD50DNA修复蛋白Rad50抗体
hz-11231R RECQL5RecQ解旋酶样蛋白5抗体
hz-11232R RECQL5RecQ解旋酶样蛋白5抗体
hz-11233R RPA70单链结合蛋白70抗体
hz-11996R Retinal S antigen视网膜S抗原抗体
hz-11971R RAMP2受体活性修饰蛋白2抗体
hz-11972R RAMP3受体活性修饰蛋白3抗体
hz-11979R Rasgrp1Ras蛋白特异鸟嘌呤核苷酸释放因子1抗体
hz-7765R RAB35RAS相关蛋白癌基因Rab35抗体
hz-7767R phospho-RACGAP1(Ser387)磷酸化Rho GTP酶激活蛋白GAP抗体
hz-7921R Robo2轴突导向受体蛋白2抗体
hz-8501R RGAG4RGAG4蛋白抗体
hz-11618R RTP4受体转运蛋白4抗体
hz-2186R RAD51C乳腺癌和卵巢癌易感基因RAD51C抗体
hz-3365R Phospho-RSK3 (Thr353 + Thr356)磷酸化核糖体蛋白S6激酶家族RSK3抗体
hz-3366R Phospho-RSK3 (Thr356 + Ser360)磷酸化核糖体蛋白S6激酶家族RSK3抗体
hz-3382R Phospho-RASGRF1 (Ser916)磷酸化Ras特异性鸟嘌呤核苷酸释放因子1
hz-3367R Phospho-RSK2 (Ser227)磷酸化核糖体S6激酶RSK2抗体
hz-3368R Phospho-RSK2(Tyr529)磷酸化核糖体S6激酶RSK2抗体
hz-3375R phospho-c-Raf (Ser259)磷酸化原癌基因c-Raf抗体
hz-3376R phospho-c-Raf(Ser296)磷酸化原癌基因c-Raf抗体
hz-3377R phospho-c-Raf(Ser338)磷酸化原癌基因c-Raf抗体
hz-3380R Phospho-Rb (Ser807 + Ser811)磷酸化视网膜母细胞瘤相关蛋白1抗体
hz-3452R Phospho-Rb (Thr821)磷酸化视网膜母细胞瘤相关蛋白1抗体
hz-3559R RaptormTOR相关调控蛋白抗体
hz-3381R Phospho-Raptor (Ser792)磷酸化mTOR相关调控蛋白抗体
hz-3372R phospho-c-Raf (Ser289)磷酸化原癌基因c-Raf抗体
hz-3564R RICTOR雷帕霉素靶蛋白复合体2抗体
hz-3562R RelB核转录因子NFKB-RelB蛋白抗体
hz-3556R Rad17细胞周期检控Rad17蛋白抗体(复制因子C)
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验人转录因子E2F1 ( E2F1 )ELISA 试剂盒 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 E2F1 单抗包被于酶标板上,标准品和样品中的 E2F1与单抗结合,加入生物素化的抗人 E2F1 ,形成免疫复合物连接在板上,辣根过氧化物酶标记的 Streptavidin 与生物素结合,加入底物工作液显蓝色,最后加终止液硫酸,在 450nm 处测 OD 值,E2F1 浓度与 OD 值成正比
X性联无丙种球蛋白血症(X-linked agammagl,bulinemia,XLA)是临床上首次确定的体液免疫缺陷病,由Brutor于1952年报道,故又称Bruton病。XLA作为常见的原发性免疫缺陷病之一,特点为血清中各类免疫球蛋白缺乏,或只能测得微量的抗体。外周血和淋巴组织中B细胞减少或完全缺乏,淋巴结中无生发中心和浆细胞。本病起病早,在出生数月后当患儿体内的母源性抗体水平下降时开始发病。临床表现为反复化脓性感染,患者细胞免疫功能不受影响(部分患者有T细胞数量减少),主要缺陷
A c-Kit (2B8) FITC-IgG2b, 01904D FITC-IgG2b Isotype control, 11184C Fc RII block (clone 2.4G2), 01241D Media: Heat inactivated FBS (56°C x 30 min) PBS + 2% heat-inactivated
技术资料暂无技术资料 索取技术资料





